Five years ago, David De Munter had the idea to develop a new type of patch during his hospital treatment for cancer. The patch enables every patient with an intravenous catheter to take a shower independently. Shortly after, the product was patented worldwide, and the patch was named Bedalpatch.
On May 12, 2015, the company announced that a financing round with the Limburg investment company LRM and a consortium of private investors have been completed. Through the entry from these investors the industrial production for the patch is initiated, and the market launch is planned for autumn 2015.
According to creator and co-founder, David De Munter, the Bedalpatch has advantages for all parties: "Hospitals have an enormous benefit here: the use of such a plaster results in a significant cost reduction in terms of labour and materials. The patch also contributes to the daily hygiene of the patient. Less handling is needed to detach the catheter, which is in line with the recommendations for decreasing the risk of infections.”
Demonstration of the Showerpatch
Bedal finds its strength in the coalition with 2 co-founding partners, Alexander Van Damme and Falk Beerten, who turned the idea into a successful company supported by the IWT and FlandersCare. The University Hospital of Leuven and homecare organization Remedus were closely involved in the process of development of the patch. At this stage the company is investigating to develop derivate products.